Innovative Stable Isotope Labelling
Platform for stable-isotope labelling (13C, 15N and 2H) of compounds
PLI Technologies uses an innovative, proprietary technology for uniform labelling with stable (non radio active) isotopes of a wide range of pro- and eukaryotic species. We offer labelled cell biomass, extracts and purified compounds.
This technology allows cost-effective production of labelled biomolecules (from small metabolites up to large, including protein therapeutics or drug targets such as e.g. GPCRs) in insect and mammalian cell lines and can be used for 3D structure determination and in silico drug design.
PLI Technologies uses an innovative, proprietary technology for uniform labelling with stable (non radio active) isotopes of a wide range of pro- and eukaryotic species. We offer labelled cell biomass, extracts and purified compounds.
This technology allows cost-effective production of labelled biomolecules (from small metabolites up to large, including protein therapeutics or drug targets such as e.g. GPCRs) in insect and mammalian cell lines and can be used for 3D structure determination and in silico drug design.
Multi-species screening and Non-invasive analysis
Other applications include monitoring the composition of biomass (protein, lipid, carbohydrate, fatty acid saturation level etc), monitoring growth and harvesting moments, optimizaing biorefinery / bioprocessing, characterization of chemical composition and screening new sources of biologically active compounds, using FT-IR.